CDC: Tuberculosis Case Counts, Rates Increasing Since 2020
By Elana Gotkine HealthDay Reporter
MONDAY, April 1, 2024 -- Tuberculosis (TB) case counts and rates have been increasing since 2020, according to research published in the March 28 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Paula M. Williams, Dr.P.H., from the CDC in Atlanta, and colleagues obtained TB case counts from the National TB Surveillance System. Rates were calculated overall and by jurisdiction, birth origin, race and ethnicity, and age group.
The researchers found that TB case counts and rates increased each year since 2020. A total of 9,615 cases were provisionally reported by the 50 U.S. States and the District of Columbia during 2023, representing a 16 percent increase versus 2022. In 2023, the rate also increased compared with 2022 (2.9 versus 2.5 per 100,000 persons). Increases in both case counts and rates were seen in 2023 in 40 states and Washington D.C. Among all age groups and both U.S-born and non-U.S.-born individuals, there were increases observed in national case counts.
"Renewed progress toward TB elimination will require strong public health systems both domestically and globally that are responsive to health disparities, capable of maintaining essential disease prevention and control activities, and prepared to withstand the next pandemic or other large-scale crisis," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Persistent Disparities Seen by Race/Ethnicity in Incidence of TB
TUESDAY, April 2, 2024 -- Persistent disparities by race/ethnicity are seen in the incidence of tuberculosis (TB), according to a study published online April 2 in the Annals of...
Dexamethasone No Benefit in HIV-Positive With Tuberculous Meningitis
THURSDAY, Oct. 12, 2023 -- For HIV-positive adults with tuberculous meningitis, adjunctive dexamethasone does not confer a benefit with respect to survival, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.